Snowball logo
logo
1345

China Pioneer Pharma Holdings Ltd

1345 โ€ข HK
HK$2.195HK$0.00ย  (0%)
Estimate
Beta
-0.157
Growth
Revenue, YoY
-31.41%
Net income, YoY
-44.72%
Dividends
Dividend yield
4.92%
Annual payout
HK$0.11
Next ex. div date
December 3, 26
Payout
77.71%
Div.growth, 5y
-9.89%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
1345
ISIN
KYG2162L1068
Country
China
Sector (GICS)
Healthcare
Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People's Republic of China. It offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas; and medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company also engages in the sale of ancillary tools, and imported in-licensed prescription products, as well as accessories leasing; research and development of denture and implants dentistry; sale of household appliances; and provision of metal finishing, management consulting, information consulting, and market information services. It sells its products to hospitals, medical institutions, and pharmacies. The company was formerly known as China Pioneer Pharma Holdings Limited. Shanghai Pioneer Holding Ltd was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pioneer Holding Ltd is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.

Frequently asked questions

What sector does China Pioneer Pharma Holdings Ltd (1345) operate in?

China Pioneer Pharma Holdings Ltd belongs to the Healthcare sector and operates in the Pharmaceutical Retailers industry.

What is China Pioneer Pharma Holdings Ltd (1345) current stock price?

As of the latest data, China Pioneer Pharma Holdings Ltd stock price is HK$2.20, with a previous close of HK$2.20.

What is China Pioneer Pharma Holdings Ltd (1345) current market capitalization?

China Pioneer Pharma Holdings Ltd market cap is approximately 2.54 billion.

What is China Pioneer Pharma Holdings Ltd (1345) EBITDA?

China Pioneer Pharma Holdings Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 78.48 million.

Does China Pioneer Pharma Holdings Ltd (1345) pay dividends?

Yes. China Pioneer Pharma Holdings Ltd pays semiannual dividends with an annualized yield of 4.92% and an estimated annual payout of HK$0.11 per share.

When is the next ex-dividend date for China Pioneer Pharma Holdings Ltd (1345)?

The next ex-dividend date is scheduled for December 03, 2026.

What is China Pioneer Pharma Holdings Ltd (1345) beta (volatility) score?

China Pioneer Pharma Holdings Ltd has a beta of -0.157, indicating lower volatility than the overall market.